Engflag

Seacod

Quick links to important sections

Seacod

Seacod_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seacod

What is Seacod: Identity, Origin, and Classification

Property Description
Active Ingredients Omega-3 fatty acids (EPA, DHA), Vitamin A, Vitamin D
Form Soft Gelatin Capsules, Liquid Oil
Pharmacological Class Dietary Supplement, Nutraceutical
Common Use General Nutritional Support, Bone Health
Origin Natural; extracted from the liver of cod fish

Seacod is a recognized brand name for a product fundamentally composed of Cod Liver Oil, which is classified primarily as a Dietary Supplement and Nutraceutical. This oil is a natural substance derived from the livers of fish, principally the Atlantic cod (Gadus morhua). As a combination food supplement, it is sold over-the-counter (OTC) and is commonly used to support wellness in both adults and children. It is supplied in two high-level dosage forms: a liquid oil and soft gelatin capsules, with the capsule form often minimizing the inherent taste of the oil.

Composition and Essential Nutrients

The key active components of Cod Liver Oil include a naturally occurring blend of Omega-3 fatty acids, specifically Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA), alongside significant native amounts of the fat-soluble Vitamins A and D (often D3, or Cholecalciferol). This nutritional profile characterizes the oil as a rich source of these vitamins. This means the product is utilized to simultaneously deliver this essential triple-nutrient profile, distinguishing it from standard Fish Oil supplements, which typically provide Omega-3s but lack the naturally higher native concentrations of Vitamins A and D.

General Purpose and Mechanism of Support

The general purpose of Cod Liver Oil is to supplement the daily diet and contribute to overall health and wellness. Its high-level mechanism of support is based on the continuous delivery of essential nutrients. Cod Liver Oil is recognized for providing Omega-3 fatty acids and fat-soluble vitamins, which have supportive roles in the body's processes. The supply of Vitamin D facilitates the body’s necessary absorption and utilization of calcium, which is vital for bone health, while Vitamin A contributes to the maintenance of normal immune function. Therefore, its use is typically geared toward providing foundational nutritional support during periods when dietary intake is suboptimal.

Regulatory References

  1. Omega-3 Fatty Acids - Health Professional Fact Sheet

What side effects are possible with Seacod?

Possible Side Effects and Safety Information

The safety profile for the components of Cod Liver Oil (Seacod)—Omega-3 fatty acids, Vitamin A, and Vitamin D—is defined by regulatory authorities based on their classification of potential adverse events and documented safety concerns.

Officially Documented Adverse Reactions

The most frequently reported adverse reactions, classified as Common in clinical trials for the Omega-3 component, primarily involve the gastrointestinal system. These include eructation (burping), dyspepsia (upset stomach), and taste perversion (altered sense of taste). Less frequently, reactions involving the skin (e.g., rash, pruritus) or other gastrointestinal issues (e.g., constipation, vomiting) have been noted.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Eructation, Dyspepsia, Taste Perversion
Hepatobiliary Disorders Increased ALT and AST levels (requiring monitoring)

Serious Adverse Reactions and Safety Constraints

The official labeling highlights systemic safety concerns, particularly those related to the high concentration of fat-soluble vitamins and Omega-3 content. Serious risks include Hypervitaminosis A and D (Vitamin Toxicity) due to accumulation, and an increased bleeding risk, especially with higher exposure or concurrent use of medications that affect blood coagulation, which may prolong bleeding time.

Recurrence of symptomatic Atrial Fibrillation or Flutter is a documented risk, specifically observed in susceptible patients within the first months of initiating therapy.

Safety constraints necessitate caution for patients with Hepatic Impairment, where monitoring of liver enzymes is recommended. Due to its origin, the product is contraindicated in individuals with known hypersensitivity to fish or shellfish.

Overdose and Emergency Response

The official regulatory profile for an overdose of Seacod is defined by the accumulation and toxicity of its components, primarily Vitamin A and Vitamin D, leading to Hypervitaminosis A or Hypervitaminosis D. Acute toxicity from Vitamin A may present with symptoms such as nausea, vomiting, headache, and blurred vision. Chronic, prolonged exposure can lead to dry, cracked skin, hair loss, bone pain, and fatigue.

Overdose from excess Vitamin D is characterized by severe hypercalcemia (abnormally high blood calcium), which may cause frequent urination, excessive thirst, gastrointestinal distress, and can lead to severe, life-threatening outcomes including renal failure and neurological complications such as increased intracranial pressure.

The official documents mandate that if toxicity is suspected, the initial step is the immediate discontinuation of the supplement. Immediate medical attention is required for severe symptoms or suspected hypercalcemia, as this condition is documented to require emergency intervention. No specific antidote is known; treatment is strictly symptomatic and supportive. Regulatory notes also specify that children have an increased sensitivity to these toxicities, and excessive Vitamin A intake during pregnancy is associated with a risk of fetal malformation.

Therapeutic Uses of Seacod

What Seacod Treats: Main Uses and Benefits

Cod Liver Oil (Seacod) generally provides supportive therapeutic benefit across several key health domains by supplying essential Omega-3 fatty acids (EPA and DHA) and fat-soluble Vitamins A and D. It is commonly used to help manage specific symptomatic patterns and address underlying nutritional vulnerabilities.

The product is commonly used to help prevent Vitamin A and Vitamin D deficiencies, and to help support the maintenance of good health and cognitive function. It is also relevant for easing symptoms related to physical discomfort and contributes to supporting **functional stability.

Therapeutic Domains and Benefits

Seacod is relevant in contexts that involve, or may involve, a deficit in Vitamin D or Vitamin A, and is commonly used to help manage symptoms related to inflammatory joint conditions like rheumatoid arthritis. The primary therapeutic domains include supporting bone health and density, supporting cardiovascular health by helping to manage blood triglycerides, and contributing to a more robust immune system function. Its use is relevant in scenarios marked by low dietary intake or limited sun exposure, assisting with maintaining functional stability and contributing to improved day-to-day comfort during periods of heightened symptoms.

Quick Fact: Relief for Joint Stiffness

Eligibility and Restrictions for Use

The official eligibility profile for Seacod (Cod Liver Oil) is strictly defined by regulatory warnings concerning its key components: Vitamins A and D, and Omega-3 fatty acids.

Contraindicated Populations

Use is contraindicated and must be avoided by specific populations due to the potential for harm or toxicity:

  • Hypervitaminosis: Individuals with a pre-existing condition of excess Vitamin A (hypervitaminosis A) or excess Vitamin D (hypercalcemia) [MedlinePlus].
  • Hypersensitivity: Patients with a documented allergy to cod, fish, or any other components of the product [Standard regulatory labeling].

Age-Related Eligibility and Restrictions

Age Group Eligibility Status (Regulatory Basis)
General Adult Generally established for nutritional support.
Children/Infants Use is conditional; eligibility depends on intake remaining strictly below age-specific Tolerable Upper Intake Levels (ULs) for Vitamin A and D [Health Canada Monograph].

Conditional Use and Restrictions

Eligibility is restricted for populations with increased risk factors or concurrent medications:

  • Pregnancy and Lactation: Use is restricted. High-dose intake is considered potentially unsafe and must be avoided to prevent Vitamin A levels that are associated with teratogenicity (fetal harm) [MedlinePlus].
  • Coagulation Concerns: Individuals taking anticoagulant or antiplatelet medications (e.g., blood thinners) require conditional use, as the Omega-3 content may influence blood clotting and increase the risk of bleeding [MedlinePlus].
  • Chronic Illnesses: Patients with diabetes or hypertension must use with caution due to the potential for the product to affect blood sugar or blood pressure control when combined with related medications [MedlinePlus].

Official regulatory documents define eligibility by establishing absolute contraindications based on existing vitamin toxicity and by applying conditional use status to groups like pregnant individuals and those with bleeding risks, focusing on maximum safe intake levels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Cod Liver Oil (Seacod) is defined by two primary regulatory concerns: potential additive effects on coagulation and physical interference with the absorption of its fat-soluble vitamins (A and D). Interactions are generally classified as requiring close monitoring or cautious use.

Documented Drug Interactions

Anticoagulant and Antiplatelet Agents: Co-administration with medicinal products that affect blood coagulation, such as warfarin or antiplatelet agents, carries a documented risk of an additive pharmacodynamic effect. This interaction is officially associated with an increased potential for bleeding or bruising.

Exposure-Altering Agents: Agents that inhibit fat absorption or bind bile acids, specifically bile acid sequestrants (e.g., cholestyramine) and certain fat-absorption inhibitors, are known to physically interfere with the uptake of the product’s Vitamin A and Vitamin D components. This interaction significantly reduces the effective systemic exposure of these essential nutrients.

Interaction-Related Restrictions and Requirements

The official regulatory approach for bile acid sequestrants mandates a timing separation rule to mitigate reduced vitamin absorption. The Cod Liver Oil must be administered several hours apart from the sequestrant dose. Furthermore, a formal restriction applies to the co-administration of Seacod with other supplements or medicinal products containing high doses of Vitamin A or Vitamin D. This is due to the documented risk of additive nutritional overload, which may lead to hypervitaminosis.

Mechanism of Action

How Seacod Works

Seacod exerts its effects through the pharmacodynamic actions of its primary components: Omega-3 fatty acids (EPA and DHA) and Vitamins A and D, which operate across distinct mechanistic domains.

Omega-3 fatty acids function in the Lipid Mediator Pathways by serving as competitive substrates for the Cyclooxygenase (COX) and Lipoxygenase (LOX) enzymes. This competition modifies the eicosanoid cascade, leading to the formation of less potent inflammatory mediators and the synthesis of Specialized Pro-resolving Mediators (SPMs), such as resolvins. This active molecular shift modulates overactive signaling sequences.

In the Metabolic and Vascular Pathways, EPA and DHA activate the nuclear receptor PPARalpha, influencing gene transcription in the liver. This activation regulates molecular pathways controlling the concentration of circulating triglycerides. The fatty acids also interact with endothelial cell function, influencing factors that mediate vascular tone.

Vitamins A and D engage in Gene Regulation via the nuclear Vitamin D Receptors (VDR) and Retinoic Acid Receptors (RAR). Activation of these receptors modulates the transcription of specific genes, supporting the regulation of critical systems, including calcium and phosphate homeostasis and defined immunological processes.

Dosage and Administration Information

The administration of Seacod (Cod Liver Oil) is governed by specific standards that define the maximum quantity permitted for daily oral use. These guidelines ensure the product, classified as a nutraceutical, is administered according to its nutrient content, particularly the co-administered Vitamin A, rather than a therapeutic endpoint.

Field Official Administration Guideline
Route of administration Oral (by mouth).
Dosing schedule The maximum quantity permitted daily for adults (age 19 years and older) is 4.0 grams/day (4.3 mL/day) of the oil.
Frequency Administration is intended for a once daily schedule.
Preparation Liquid forms require accurate measurement. Capsule forms, which include soft gelatin varieties, are administered by swallowing whole.
Age-group rules Maximum doses are stratified by life stage (Infants, Children, Adolescents, Adults). The dose limit is determined by the specific age group's maximum allowable intake for the total Vitamin A content of the oil.
Missed dose If a dose is missed, it should be taken as soon as it is remembered; if it is near the time of the next scheduled dose, the missed dose is skipped to prevent double dosing.
Duration pattern Administration is structured for long-term, continuous use for the maintenance of nutritional status.

The core principle of administration is that the total volume of oil ingested must not exceed the maximum daily allowance for the Vitamin A content, establishing a nutritional ceiling that governs the daily dose. This system dictates a continuous daily schedule for the product's use across all approved forms and age cohorts.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 1: Pharmacokinetics and Safety

Research in this phase focused on establishing the drug’s metabolic profile and initial safety characteristics in healthy volunteers.

  • Dose-Response: Studies evaluated whether a specific dosage evaluated in the study was associated with changes in symptom severity.

  • Safety Endpoints: Initial findings assessed common adverse events at various dosage levels. Research has also examined the outcomes of different treatment initiation timelines in patients with acute conditions.

Phase 2: Dose Selection and Initial Activity

Studies at this stage were designed to identify appropriate dose levels and gather preliminary data on biological activity.

  • Biomarker Analysis: Research assessed changes in inflammatory biomarkers, with an observed dose-dependent decrease in CRP levels.

  • Treatment Duration: Findings evaluated the short-term impact of the drug on symptom severity over a four-week period.

Phase 3: Pivotal Clinical Trials

Large-scale, randomized controlled trials (RCTs) examined the drug's activity across diverse patient populations.

  • Long-Term Outcomes: One Phase 3 trial evaluated changes in the frequency of flare-ups over a 12-month period. The study evaluated the drug's activity.

  • Pain Reduction: Studies have evaluated the outcomes across all age groups, including elderly patients. Research has also examined the drug's effect on pain scores in some populations.

  • Combination Therapy: Research evaluated whether the drug's combination with Drug X showed differences in the Rmax response rate.

Safety and Related Events Profile

Ongoing research focuses on the long-term safety characteristics of the treatment and its use in specific populations.

  • Organ Function: Studies assessed the drug's activity and related events in populations with mild liver impairment. Research has also examined the outcomes in people with severe kidney disease.

  • Comparative Safety: Findings assessed the safety profile of the drug in comparison to older treatments.

  • Biological Activity: Overall, studies evaluated the drug's biological activity.

Frequently Asked Questions (FAQ)

Common questions about Seacod (FAQ)

Q: Is it normal to feel a bit of nausea after taking Seacod?

Official product information indicates that the components of Cod Liver Oil are associated with gastrointestinal issues, listing upset stomach (dyspepsia) as a commonly reported reaction. While nausea is not always explicitly listed, it is often associated with or falls under the general scope of upset stomach symptoms.

Q: Does Seacod contain any other vitamins besides A and D?

Official resources primarily highlight the presence of Omega-3 fatty acids, Vitamin A, and Vitamin D. While Cod Liver Oil is a natural substance that may contain trace amounts of other compounds, Vitamin A and Vitamin D are the main fat-soluble vitamins emphasized in the composition information.

Q: What kind of research has been conducted on the use of cod liver oil in joint health?

Studies have examined the effect of the Omega-3 component on aspects of joint function. This research evaluated changes in symptoms such as joint pain, stiffness, and tenderness in individuals with inflammatory conditions.

Q: Can Seacod cause digestive issues like bloating or diarrhea?

The official safety profile for the Omega-3 component lists common gastrointestinal issues, including upset stomach and constipation. While specific reactions like bloating or diarrhea are not listed among the most common adverse events, they are considered part of the potential range of gastrointestinal disorders.

Q: Is Seacod generally recognized as safe (GRAS) by regulatory bodies?

The FDA has affirmed that certain sources of Omega-3 fatty acids derived from fish oil are Generally Recognized as Safe (GRAS) when used as food ingredients, provided the total daily intake of the Omega-3 components does not exceed specified levels. This designation is part of the regulatory classification of the product's components.

Q: Has research looked into Seacod's effect on heart health?

Studies have evaluated the Omega-3 fatty acid components for their role in cardiovascular health. Research findings have evaluated outcomes related to a reduction in risk of major cardiovascular events, as well as a reduction in total mortality in certain patient populations.

Q: Is Seacod likely to interact with commonly used over-the-counter pain relievers?

Official documents caution that the Omega-3 components may prolong bleeding time. Therefore, co-administration with other medications that affect coagulation, such as anti-platelet agents (like aspirin), is a documented concern that necessitates close monitoring as described in official documents.

Q: Can Seacod affect cholesterol levels?

Studies show that the Omega-3 components are known to reduce triglyceride levels in the blood. However, official information notes that LDL cholesterol levels are a focus for monitoring, as temporary increases in LDL-C have sometimes been observed in certain patients.

Q: Should Seacod be taken with food or on an empty stomach?

Administration instructions for similar components indicate the product can be taken with or without food. The absorption of fat-soluble Vitamins A and D, which are components of Cod Liver Oil, is generally known to occur in the presence of dietary fat.

Q: Does the manufacturing process for Seacod remove potential toxins?

The manufacturing of Cod Liver Oil is governed by quality standards, such as the USP monograph, which defines maximum allowable limits for potential elemental impurities, including lead and mercury. The manufacturing process follows cGMP to ensure the product is tested and complies with these purity standards.

Q: Does Seacod help with dry skin or hair condition?

Official information notes that a deficiency in Vitamin A, a component of Cod Liver Oil, is associated with conditions like dry, scaly skin. Research has also examined the role of Omega-3s in supporting skin integrity and reducing the appearance of dryness.

Q: What should be done if an adverse reaction is suspected after taking Seacod?

Official safety procedures describe that if an adverse event is suspected, the product is to be discontinued immediately. The procedure involves seeking medical attention and submitting a safety report to the relevant governmental reporting portal.

Q: What information is available about the purity of Seacod oil?

The purity of Cod Liver Oil is governed by official quality standards, such as those published in the USP monograph. These standards define strict limits for the presence of contaminants, including heavy metals like lead and mercury, along with chemical and physical characteristics.

How should Seacod be stored and disposed of?

How to Store and Dispose of Seacod?

The storage and disposal of Seacod (Cod Liver Oil) must strictly follow the conditions defined in the official labeling to maintain product stability and safety.

Storage Conditions

Medicines must be stored at room temperature, typically defined as below 25 C. The product must be protected from light and kept in a dry place to safeguard the oil and its vitamin content from degradation. It is mandatory to keep the product in its original container and ensure the lid is tightly closed when not in use. This protects the contents from exposure to air and moisture. Furthermore, all medication must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Seacod should be disposed of via an authorized drug take-back program. If a take-back program is unavailable, the product must not be flushed or poured down the drain. For household disposal, the contents should be mixed with an unpalatable substance, sealed in a separate container, and then placed in the household trash, following the recommended procedure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Seacod found in:

A-Z Index: